Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Consensus Rating of “Buy” from Brokerages

Cellebrite DI Ltd. (NASDAQ:CLBT) has been given an average rating of “Buy” by the eight ratings firms that are currently covering the company, Marketbeat reports. Eight equities research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have covered the stock in the last year is $20.29.

A number of equities analysts recently issued reports on CLBT shares. Craig Hallum upped their price objective on shares of Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Thursday, November 7th. TD Cowen increased their price target on Cellebrite DI from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Monday, September 23rd. Deutsche Bank Aktiengesellschaft boosted their price objective on Cellebrite DI from $15.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, August 16th. JPMorgan Chase & Co. increased their target price on Cellebrite DI from $21.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, November 7th. Finally, Lake Street Capital boosted their price target on Cellebrite DI from $13.50 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 16th.

Cellebrite DI Trading Down 1.7 %

Shares of Cellebrite DI stock opened at $20.04 on Friday. The company has a 50 day moving average of $18.88 and a 200-day moving average of $15.69. The company has a market cap of $4.13 billion, a PE ratio of -12.93, a price-to-earnings-growth ratio of 2.91 and a beta of 1.51. Cellebrite DI has a 1-year low of $7.91 and a 1-year high of $21.72.

Cellebrite DI (NASDAQ:CLBT) last issued its earnings results on Wednesday, November 6th. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.05. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The firm had revenue of $106.90 million for the quarter, compared to the consensus estimate of $102.06 million. During the same quarter last year, the business posted $0.09 EPS. The company’s revenue was up 27.0% compared to the same quarter last year. Research analysts forecast that Cellebrite DI will post 0.32 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Tidal Investments LLC grew its holdings in Cellebrite DI by 59.3% during the 3rd quarter. Tidal Investments LLC now owns 104,478 shares of the company’s stock worth $1,759,000 after acquiring an additional 38,887 shares during the period. Barclays PLC grew its stake in Cellebrite DI by 29.1% during the third quarter. Barclays PLC now owns 263,657 shares of the company’s stock worth $4,439,000 after purchasing an additional 59,395 shares during the period. Public Employees Retirement System of Ohio bought a new stake in Cellebrite DI in the third quarter worth approximately $4,936,000. Y Intercept Hong Kong Ltd lifted its stake in Cellebrite DI by 35.5% in the third quarter. Y Intercept Hong Kong Ltd now owns 19,510 shares of the company’s stock valued at $329,000 after buying an additional 5,113 shares during the period. Finally, XTX Topco Ltd boosted its holdings in shares of Cellebrite DI by 66.0% during the 3rd quarter. XTX Topco Ltd now owns 56,360 shares of the company’s stock worth $949,000 after buying an additional 22,416 shares in the last quarter. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.